🇺🇸 FDA
Patent

US 7504515

Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7504515 (Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/18, A61P11/00